BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 7644663)

  • 1. Inhaled epinephrine for anaphylaxis: Time for another look?
    Shaker MS; Golden DBK; Lieberman JA; Greenhawt M; Lee MW
    Ann Allergy Asthma Immunol; 2024 Mar; 132(3):267-269. PubMed ID: 38072310
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal Anaphylaxis Associated With the Gadolinium-Based Contrast Agent Gadoteridol (ProHance).
    Takahashi S; Takada A; Saito K; Hara M; Yoneyama K; Nakanishi H
    J Investig Allergol Clin Immunol; 2015; 25(5):366-7. PubMed ID: 26727767
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse reaction to intravenous gadoteridol.
    Shellock FG; Hahn HP; Mink JH; Itskovich E
    Radiology; 1993 Oct; 189(1):151-2. PubMed ID: 8372186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
    Witte RJ; Anzai LL
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):523-4. PubMed ID: 8197951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe anaphylactoid shock secondary to gadolinium contrast media.
    Simons CW; Benouni S; Gibbon G; Klaustermeyer W
    Ann Allergy Asthma Immunol; 2009 Oct; 103(4):359-60. PubMed ID: 19852205
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaphylaxis to trometamol excipient in gadolinium-based contrast agents for clinical imaging.
    Lukawska J; Mandaliya D; Chan AWE; Foggitt A; Bidder T; Harvey J; Stycharczuk L; Bisdas S
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1086-1087. PubMed ID: 30217530
    [No Abstract]   [Full Text] [Related]  

  • 7. Epinephrine administration for severe adverse reactions to contrast agents.
    Samett EJ; Espinosa GA
    Radiology; 1995 Sep; 196(3):879. PubMed ID: 7644663
    [No Abstract]   [Full Text] [Related]  

  • 8. [Artificial contrasting during magnetic resonance tomography].
    Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
    Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
    [No Abstract]   [Full Text] [Related]  

  • 9. Anaphylaxis after first exposure to gadoterate meglumine: a case report and literature review.
    Bianchi L; Hansel K; Marietti R; Tramontana M; Stingeni L
    J Allergy Clin Immunol Pract; 2018; 6(6):2124-2126. PubMed ID: 29559210
    [No Abstract]   [Full Text] [Related]  

  • 10. Gadolinium-Induced Fibrosis.
    Todd DJ; Kay J
    Annu Rev Med; 2016; 67():273-91. PubMed ID: 26768242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of magnetic resonance imaging contrast agents.
    Shellock FG; Kanal E
    J Magn Reson Imaging; 1999 Sep; 10(3):477-84. PubMed ID: 10508312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of magnetic resonance contrast media.
    Runge VM
    Top Magn Reson Imaging; 2001 Aug; 12(4):309-14. PubMed ID: 11687717
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.